Drawing for DRIVER GENOMICS

USPTO serial 86293082

DRIVER GENOMICS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
RINKER, ANTHONY MICHAEL
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DRIVER GENOMICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of cancerACTIVE—
035Consulting, analysis and advisory services relating to business management and operations; consulting, analysis and advisory services relating to business management and operations in the fields of clinical pharmaceutical trials, pharmaceutical research and development, laboratory testing, and diagnosticsACTIVE—
036Creation, operation and management of investment funds that invest in companies and entrepreneurs; private equity investment services; providing financing to companies and entrepreneurs; venture capital funding services; venture capital fund management; investment management; investment advisory services; investment consultation and advice; financial asset management; financial asset management consultation and advice; financial advisory services; financial research and analysis, namely, due diligence and selection services in the field of venture capital; financial services, namely, operation and management of hedge funds; hedge fund investment servicesACTIVE—
042Research and development of pharmaceutical preparations; laboratory research and testing services relating to gene sequencing-based tests; laboratory research and testing services relating to pharmaceuticals; consulting services in the fields of clinical pharmaceutical trials, pharmaceutical research and development, laboratory testing, and diagnostics; conducting clinical trials for others; compiling data for research purposes in the fields of gene sequencing, cancer research, and cancer treatment; providing an online, searchable database of research information relating to gene sequencing, cancer research, and cancer treatment; software as a services (SAAS) for use in extracting and analyzing data in the fields of gene sequencing, cancer research, and cancer treatmentACTIVE—
044Medical testing for diagnostic or treatment purposes; Medical testing for diagnostic or treatment purposes in the field of cancer; Medical testing for diagnostic or treatment purposes featuring DNA sequencingACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 16, 2019WOAGWITHDRAWAL OF ATTORNEY GRANTED—
Apr 16, 2019WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED—
Jan 11, 2017ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jan 3, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 2, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 22, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 22, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 6, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 5, 2016EX2GSOU EXTENSION 2 GRANTED—
Jul 5, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 20, 2016EXT2SOU EXTENSION 2 FILED—
May 20, 2016CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 20, 2016COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 20, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 17, 2015EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 14, 2015EX1GSOU EXTENSION 1 GRANTED—
Nov 13, 2015AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 3, 2015EXT1SOU EXTENSION 1 FILED—
Nov 3, 2015EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 2, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 7, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 7, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 18, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 3, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 3, 2015ALIEASSIGNED TO LIE—
Feb 12, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 11, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 11, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 11, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 10, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 10, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 10, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 10, 2014DOCKASSIGNED TO EXAMINER—
Aug 27, 2014ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Jun 10, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 31, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance